Aprea Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Aprea Therapeutics

15/03/2022 22:15

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 44 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Aprea Therapeutics Inc's reported EPS for the quarter was
a loss
of 36 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aprea Therapeutics Inc shares had fallen by 42.5% this
quarter.
    * The company reported a quarterly loss of $7.76 million.
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated March 15 at 10:15 p.m.  ​All
figures in US dollars unless otherwise stated